OpenU19NIAIDClinical trial: Optional / allowed
Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases (NIAID) · NIH Institute/Center · RFA-AI-27-004
Source: Grants.gov · View original posting ↗
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- $4.5M total
- DeadlineFinal application due date.
- Sep 24, 2026
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- U19
- DurationMaximum project period for a single award.
- —
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- 4
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- One-time
- Open dateWhen applications open (or opened).
- Jun 29, 2026
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $4.5M total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
Established investigatorGovernmentSmall businessHigher educationNonprofitForeign entities
Research areas
Basic mechanisms & biology
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.